Clara Rodríguez Fernández, Author at Labiotech.eu

About

Traveler, musician, food enthusiast and book worm. Always on the hunt for interesting facts and news.

Articles by Clara Rodríguez Fernández

News and Trends 22 Dec 2016

BMS Offers €850M for a British Oncolytic Virus better than CAR-T

BMS is offering PsiOxus Therapeutics a massive deal to get exclusive rights of an oncolytic virus that could outperform the promising CAR-T therapies. PsiOxus Therapeutics, based in Oxford, develops immuno-oncolytic viruses to treat solid tumors. Its technology attracted a partnership with Bristol-Myers Squibb earlier this year, which is now offering the British biotech an impressive €850M […]

December 22, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 22 Dec 2016

The 10 Biggest Clinical Success Stories of 2016 in European Biotech

What are the most impressive advances in medical biotechnology this year? From cancer to peanut allergy, here’s a list of the best success stories of 2016. Biotech is becoming a powerful driving force in medicine, providing innovative therapies that could end some of the most severe diseases. To celebrate the advances in the area of […]

December 22, 2016 - 5 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 12 19 at 4.24.40 PM e1482161199959

News and Trends 21 Dec 2016

Can partnerships between Biotechs and Academia be the Key to Success?

We had the opportunity to hear the story behind the successful Evotec by Thomas Hanke, Executive VP, who gave plenty of advice for biotech companies seeking to grow. One of the biggest biotechs in Europe, with over 1,000 employees, Evotec is now transitioning from offering services to other companies to building its own pipeline. Thomas Hanke, Executive […]

December 21, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Dec 2016

UPDATE: UniQure keeps afloat with a New CEO and More Clinical Data

UniQure’s gene therapy for Hemophilia B is performing well in clinical trials, but the company faces many challenges with its current financial situation. Can it manage to make it to the market? UniQure is famous for launching Glybera, the first globally approved gene therapy, which has been a commercial failure. The company is now indefinitely missing […]

December 20, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Dec 2016

Japanese Invasion in the European Biologicals Manufacturing space

The Japanese manufacturer AGC is acquiring CMC Biologics for nearly €500M, its second European purchase this year aimed at entering the profitable biologicals manufacturing space. CMC Biologics is a contract development and manufacturing organization (CDMO) in Copenhagen with over 500 employees that focuses on biologicals using mammalian and microbial hosts. Its services must have impressed […]

December 20, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Dec 2016

These are our 10 Most Read Biotech Articles of 2016

From the hottest research areas to the most popular city for biotech, which biotech articles have managed to hook our readers the most this year? After an exciting journey of 2 years, Labiotech.eu is now the leading biotech media in Europe, with over 50k monthly readers. To celebrate the end of another amazing year, we wanted […]

December 20, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 12 16 at 4.59.08 PM e1481904006793

News and Trends 19 Dec 2016

How is Biotech responding to Patient Advocacy in Rare Disease?

A panel of experts in rare disease discussed some of the latest trends at Labiotech Refresh, focusing on the growing patient involvement and how it is benefiting this field. Rare diseases are attracting biotech and pharma more and more since they are typically less crowded areas with unmet clinical needs. However, the lower numbers of […]

December 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 19 Dec 2016

Evotec closes the year partnering with Celgene to treat Alzheimer’s

Evotec is closing a fantastic financial year with another top-level partnership; Celgene has decided to trust in its iPSC platform to develop drugs for neurodegenerative diseases. Evotec is a successful drug discovery CRO based in Germany that has managed to sign partnerships with some of the biggest names in Biotech. In addition to previous deals with Bayer, Merck, […]

December 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Dec 2016

Microbial Dresses and a Dishcloth that tells you it’s Time to Wash it

From microbial fashion to a fabric that changes colors in the presence of pathogens, Neffa is exploring the many benefits and applications of combining microbiology and textiles. Aniela Hoitink is an artist based in Amsterdam that specializes in incorporating microbiology into textiles. Her trademark Neffa englobes a series of projects that seek to translate innovations in these […]

December 17, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 12 16 at 10.46.56 AM 1 e1481881804814

News and Trends 16 Dec 2016

Mini-Organs grown in Switzerland are Here to Change Drug Discovery

This week we travel to Lausanne, a thriving biotech hub in Switzerland. Here, QGel is working to replicate the complexity of life in vitro in lab-grown mini-organs to improve drug discovery. Cool, right? City: Lausanne, Switzerland Founded: 2009 Employees: 11-50 Financial data: Total of €12M raised (12/2016) Mission: QGel creates personalized arrays that can mimic the cellular architecture of different organs. […]

December 16, 2016 - 1 minutemin - By Clara Rodríguez Fernández

Screenshot 2016 12 16 at 10.22.38 AM e1481880436689

News and Trends 16 Dec 2016

This Gene Therapy Startup is Showing Off with a Better Viral Vector

GeneQuine wants to be one of the first to use gene therapy to treat osteoarthritis! Watch Kilian Guse’s pitch at Labiotech Refresh to find out how his startup plans to do this. “Osteoarthritis is the most common joint disorder. (…) Currently, there are only symptomatic treatments but no disease-modifying treatment“. One of the major challenges is efficient drug […]

December 16, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Dec 2016

Young Immuno-Oncology Biotechs attract Funding to Cure Metastasis

Amcure and TILT Biotherapeutics announced yesterday new financing rounds supporting the development of unique strategies to cure cancer metastasis. Amcure, in Germany, is fighting highly metastatic forms of cancer by targeting angiogenesis. The company just closed a Series B round with a total of €6M from already existing investors. With the funds, Amcure plans to accelerate […]

December 16, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Clara Rodríguez Fernández

About

Articles by Clara Rodríguez Fernández

BMS Offers €850M for a British Oncolytic Virus better than CAR-T

The 10 Biggest Clinical Success Stories of 2016 in European Biotech

Can partnerships between Biotechs and Academia be the Key to Success?

UPDATE: UniQure keeps afloat with a New CEO and More Clinical Data

Japanese Invasion in the European Biologicals Manufacturing space

These are our 10 Most Read Biotech Articles of 2016

How is Biotech responding to Patient Advocacy in Rare Disease?

Evotec closes the year partnering with Celgene to treat Alzheimer’s

Microbial Dresses and a Dishcloth that tells you it’s Time to Wash it

Mini-Organs grown in Switzerland are Here to Change Drug Discovery

This Gene Therapy Startup is Showing Off with a Better Viral Vector

Young Immuno-Oncology Biotechs attract Funding to Cure Metastasis

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Clara Rodríguez Fernández

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!